Literature DB >> 20929327

IDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status.

Ivana Jeziskova, Filip Razga, Monika Bajerova, Zdenek Racil, Jiri Mayer, Dana Dvorakova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20929327     DOI： 10.3109/10428194.2010.523126

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

1.  The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.

Authors:  Charlotte Pawlyn; Martin F Kaiser; Christoph Heuck; Lorenzo Melchor; Christopher P Wardell; Alex Murison; Shweta S Chavan; David C Johnson; Dil B Begum; Nasrin M Dahir; Paula Z Proszek; David A Cairns; Eileen M Boyle; John R Jones; Gordon Cook; Mark T Drayson; Roger G Owen; Walter M Gregory; Graham H Jackson; Bart Barlogie; Faith E Davies; Brian A Walker; Gareth J Morgan
Journal:  Clin Cancer Res       Date:  2016-05-27       Impact factor: 12.531

2.  Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype.

Authors:  Marijana Virijevic; Teodora Karan-Djurasevic; Irena Marjanovic; Natasa Tosic; Mirjana Mitrovic; Irena Djunic; Natasa Colovic; Ana Vidovic; Nada Suvajdzic-Vukovic; Dragica Tomin; Sonja Pavlovic
Journal:  Radiol Oncol       Date:  2016-09-08       Impact factor: 2.991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.